摘要
选择非ST段抬高急性冠状动脉综合征患者105例，随访30d与1年，并根据有无终点事件（心脏性死亡和非致命性心肌梗死）分为无事件组和事件组，结果示事件组的脑型利钠肽水平明显高于无事件组，随访30d时分别为（235±107）μg／L与（154±49）μg／L，随访1年时分别为（259±100）μg／L与（143±57）μg／L，均P〈0．05。而两组间年龄、性别分布及吸烟、高血压、糖尿病、高脂血症比例差异无统计学意义。提示脑型利钠肽是非ST段抬高急性冠状动脉综合征患者预后的重要预测指标。
One hundred and five patients with non-ST segment elevation acute coronary syndrome were followed up for 1 year. They were assigned to the event group or non-event group according to the presence of endpoint events （ cardiac death and nonfatal myocardial infarction）. B-type natriuretic peptide level was measured at 30 days and 1 year and compared between the two groups. The results showed that the level of B-type natriuretic peptide was higher in the event group [ （235 ± 107） μg/L vs （ 154 ±49） μg/L at 30 days ; （ 259 ± 100） μg/L vs （ 143 ±57 ） μg/L at 1 year ]. Thus, B-type natriuretie peptide is an important prognostic factor for patients with non-ST segment elevation acute coronary syndrome.
出处
《中华全科医师杂志》
2008年第3期182-183,共2页
Chinese Journal of General Practitioners
